Literature DB >> 8180209

Plasmenylethanolamine facilitates rapid membrane fusion: a stopped-flow kinetic investigation correlating the propensity of a major plasma membrane constituent to adopt an HII phase with its ability to promote membrane fusion.

P E Glaser1, R W Gross.   

Abstract

A critical step in membrane fusion involves the formation of a lipid intermediate which shares a conformational similarity with an inverted hexagonal phase (HII). Since plasmenylethanolamines possess a marked propensity for hexagonal phase formation and represent a major lipid constituent of several membrane systems which undergo rapid membrane fusion (e.g., plasma membranes and synaptic vesicle membranes), we compared the relative fusogenicity of lipid vesicles containing plasmenylethanolamine to that of vesicles containing their diacyl phospholipid counterpart (i.e., phosphatidylethanolamine). Vesicles comprised of equimolar mixtures of phosphatidylcholine and phosphatidylethanolamine fused slowly with phosphatidylserine vesicles in the presence of 10 mM CaCl2, as assessed either by lipid mixing (dequenching of octadecyl rhodamine fluorescence, 7.4 Fmax% s-1) or internal contents mixing (fluorescence enhancement from the resultant Tb/dipicolinic acid charge transfer complex, 8.7Fmax% s-1). In stark contrast, vesicles comprised of equimolar mixtures of phosphatidylcholine and plasmenylethanolamine fused three times more rapidly, as assessed by both lipid mixing (22.1 Fmax% s-1) and internal contents mixing (21.4Fmax% s-1) assays. The importance of an HII-like intermediate in membrane fusion was further substantiated by demonstration that plasmenylethanolamines containing arachidonic acid at the sn-2 position (which demonstrate a greater propensity for HII phase formation) exhibited the most rapid rate of membrane fusion (five times greater than phosphatidylethanolamine containing oleic acid at the sn-2 position). Furthermore, vesicles containing plasmenylethanolamines in physiologic ratios with other phospholipids (i.e., PC/PE/PS, 45:45:10, mol/mol) underwent fusion six times more rapidly (4.4Fmax% min-1) than corresponding vesicles in which plasmenylethanolamine was replaced with phosphatidylethanolamine (0.7Fmax% min-1).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8180209     DOI: 10.1021/bi00185a019

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  69 in total

Review 1.  Membrane phospholipid alterations in Alzheimer's disease: deficiency of ethanolamine plasmalogens.

Authors:  A A Farooqui; S I Rapoport; L A Horrocks
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

2.  Impaired neurotransmission in ether lipid-deficient nerve terminals.

Authors:  Alexander Brodde; Andre Teigler; Britta Brugger; Wolf D Lehmann; Felix Wieland; Johannes Berger; Wilhelm W Just
Journal:  Hum Mol Genet       Date:  2012-03-08       Impact factor: 6.150

Review 3.  Genetic diseases of the Kennedy pathways for membrane synthesis.

Authors:  Mahtab Tavasoli; Sarah Lahire; Taryn Reid; Maren Brodovsky; Christopher R McMaster
Journal:  J Biol Chem       Date:  2020-12-18       Impact factor: 5.157

4.  Circulating ethanolamine plasmalogen indices in Alzheimer's disease: Relation to diagnosis, cognition, and CSF tau.

Authors:  Mitchel A Kling; Dayan B Goodenowe; Vijitha Senanayake; Siamak MahmoudianDehkordi; Matthias Arnold; Tyler J Massaro; Rebecca Baillie; Xianlin Han; Yuk-Yee Leung; Andrew J Saykin; Kwangsik Nho; Alexandra Kueider-Paisley; Jessica D Tenenbaum; Li-San Wang; Leslie M Shaw; John Q Trojanowski; Rima F Kaddurah-Daouk
Journal:  Alzheimers Dement       Date:  2020-07-27       Impact factor: 21.566

5.  Rapid and comprehensive 'shotgun' lipidome profiling of colorectal cancer cell derived exosomes.

Authors:  Todd A Lydic; Steven Townsend; Christopher G Adda; Christine Collins; Suresh Mathivanan; Gavin E Reid
Journal:  Methods       Date:  2015-04-20       Impact factor: 3.608

6.  Docosahexaenoic acid-containing phospholipid molecular species in brains of vertebrates.

Authors:  T Farkas; K Kitajka; E Fodor; I Csengeri; E Lahdes; Y K Yeo; Z Krasznai; J E Halver
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

7.  Effects of aging and dietary n-3 fatty acids on rat brain phospholipids: focus on plasmalogens.

Authors:  A André; P Juanéda; J L Sébédio; J M Chardigny
Journal:  Lipids       Date:  2005-08       Impact factor: 1.880

Review 8.  Potential mechanisms contributing to sulfatide depletion at the earliest clinically recognizable stage of Alzheimer's disease: a tale of shotgun lipidomics.

Authors:  Xianlin Han
Journal:  J Neurochem       Date:  2007-11       Impact factor: 5.372

9.  Seasonal influences on PCB retention and biotransformation in fish.

Authors:  Margaret O James; Kevin M Kleinow
Journal:  Environ Sci Pollut Res Int       Date:  2013-03-14       Impact factor: 4.223

10.  Disseminated neoplasia in the soft-shell clam Mya arenaria: membrane lipid composition and functional parameters of circulating cells.

Authors:  Fabienne Le Grand; Philippe Soudant; Ahmed Siah; Réjean Tremblay; Yanic Marty; Edouard Kraffe
Journal:  Lipids       Date:  2014-06-17       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.